Atlas Trials

The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.

Clinical trial NCT02618538 · COMPLETED

Trial details

NCT number
NCT02618538
Sponsor
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2015-07-01
Primary completion
2018-03-01
Enrollment
26600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.